Investigation Overview
An investigation on behalf of investors of Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares over potential securities laws violations by Akcea Therapeutics, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Akcea Therapeutic...
You must register (for free) or login to view the entire investigation.